Digital 4th Annual Antifibrotic Drug Development Summit
Evvnt Promotion / evvnt
Archiv
16.11.2020 - 18.11.2020 Online, USA
Time: 8:30 am - 6:00 pm
Kongressthemen
Now in its 4th year, the digital AFDD summit is the industry’s definitive guide to turning mechanistic understanding of fibrosis into clinically effective therapeutics across disease areas. With 3 days of in-depth cutting-edge case studies and the highest calibre of discussions from cross-disciplinary fibrosis heavy-weights, AFDD will bridge the current translational gap to anti-fibrotic drug development success
Now in its 4th year, the digital AFDD summit is the industry’s definitive guide to turning mechanistic understanding of fibrosis into clinically effective therapeutics across disease areas. With 3 days of in-depth cutting-edge case studies and the highest calibre of discussions from cross-disciplinary fibrosis heavy-weights, AFDD will bridge the current translational gap to anti-fibrotic drug development success
Zielpublikum
500
500
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Andrew Billin Senior Director, Biomarker Sciences Gilead, Bob Willette Senior Fibrosis Advisor ImmunoMet and more.
Brochure: https://go.evvnt.com/680187-4?pid=4832
Speakers: Andrew Billin Senior Director, Biomarker Sciences Gilead, Bob Willette Senior Fibrosis Advisor ImmunoMet and more.
Brochure: https://go.evvnt.com/680187-4?pid=4832
Anfragen und Anmeldung:
http://go.evvnt.com/680187-3?pid=4832
Herr Charlotte Harrison
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
Conference Only: USD 2099.0, Full Access: USD 2948.0
Conference Only: USD 2099.0, Full Access: USD 2948.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
